Wright Medical/Orthomet
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical Technology extends until Nov. 30 its offer to purchase outstanding shares of Orthomet for $11 per share of common stock and $12.09 per share of 6% convertible preferred stock. Wright is gathering information requested by the Federal Trade Commission under the Hart-Scott-Rodino anti-trust law and "is continuing to use its best efforts to provide the requested information as promptly as possible," the company says. Wright and Orthomet reached a definitive merger agreement in late October ("The Gray Sheet" Oct. 24, "In Brief")